key: cord-0797046-po1v07ib authors: Jain, Vijay Kumar; Iyengar, Karthikeyan P.; Samy, David Ananth; Vaishya, Raju title: Tuberculosis in the era of COVID-19 in India date: 2020-07-29 journal: Diabetes Metab Syndr DOI: 10.1016/j.dsx.2020.07.034 sha: 27893141f302c919e89b6cd4b6765e9c7a34e9ff doc_id: 797046 cord_uid: po1v07ib BACKGROUND AND AIMS: Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. We assess the challenges due to COVID- 19 pandemic on management of Tuberculosis and current strategies adopted to mitigate them. METHODS: We carried out a comprehensive review of the literature using suitable keywords such as ‘COVID-19’, ‘Pandemics’, ‘Tuberculosis’ and ‘India’ on the search engines of PubMed, Scopus, Google Scholar and Research Gate in the month of May 2020 during the current COVID-19 pandemic to assess the impact of COVID-19 on management of Tuberculosis. RESULTS: We found considerable disruption in Tuberculosis service provisions both in the primary care and hospital settings. Lockdown, social distancing, isolation strategies and public health guidelines to prevent viral transmission impacted the delivery of all aspects of Tuberculosis care. CONCLUSIONS: COVID-19 pandemic has had a significant impact in the delivery of various tuberculosis prevention, surveillance, and treatment programmes. Lockdown and public health guidelines have resulted in tough challenges in traditional management of tuberculosis and has required reconfiguration of methods to support patients including wider use of remote consultations. Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. We assess the challenges due to COVID-19 pandemic on management of Tuberculosis and current strategies adopted to mitigate them. We carried out a comprehensive review of the literature using suitable keywords such as 'COVID-19', 'Pandemics', 'Tuberculosis' and 'India' on the search engines of PubMed, Scopus, Google Scholar and Research Gate in the month of May 2020 during the current COVID-19 pandemic to assess the impact of COVID-19 on management of Tuberculosis. We found considerable disruption in Tuberculosis service provisions both in the primary care and hospital settings. Lockdown, social distancing, isolation strategies and public health guidelines to prevent viral transmission impacted the delivery of all aspects of Tuberculosis care. The COVID-19 pandemic due to novel coronavirus -SARS-CoV-2 is predominantly a respiratory illness and ranges from a common cold to more severe disease including pneumonia [1, 2] . The mode of human to human transmission is via droplet infections which are either inhaled or enter the body by touching infected surfaces. Currently the main treatment modality is supportive therapy, whilst serious illness may require ventilator assistance and efforts are in progress to produce an effective vaccine [3, 4] . India accounts for more than one-fourth of the world's Tuberculosis (TB) cases. This amounts to about 2.6 million cases out of 10 million cases worldwide. The disease has been the reason of death of nearly 0.44 million people in India [5] . One third of the global drugresistant TB cases are in India, according to the World Health Organisation (WHO) [6] . COVID-19 pandemic has presented us with a global health crisis. However national programmes to combat TB need to be actively engaged ensuring an effective, rapid response to COVID-19 whilst maintaining TB services [7] . Though the mode of transmission differs slightly, both TB and COVID-19 spread by close contact between people. As TB remains a significant communicable disease in India, surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens should still remain a public health priority in presence of COVID-19 pandemic. COVID-19 pandemic has made significant restrictions on 'face to face' assessments and movement of people due to national lockdown and infection control strategies [8, 9] . We assess the impact of COVID-19 on TB management including surveillance and monitoring and current strategies adopted to mitigate them. keep the clinics open so people with tuberculosis symptoms do not avoid health facilities or delay their assessment due to COVID-19 pandemic must be balanced with health care risk. Multi-month dispensing will limit the hospital visits and minimize the risk of unnecessary exposure to COVID-19 infection. To reduce the pressure on facility-based health-care systems, virtual communication platforms such as e-Sanjeevani, a Government of India, integrated telemedicine solution will be helpful in assisting patients [12] . Telemedicine is already playing an emerging role in remote management of chronic illness such as diabetes mellitus [13, 14] . In line with World Health Organization (WHO) recommendations, technologies like electronic medication monitors and video-supported therapy can help patients complete their TB treatment [15] . 3.1 With the lockdown restrictions and reduction in face to face appointments, there has been increasing necessity of finding complementary ways of assisting patients with TB. Telemedicine can help in community management of TB. Case management of patients with TB can take place via video link or teleconferencing. Should patients require assistance with medications or there be a risk of compliance with medications, patients are enrolled into a DOTS programme [16] , which entails a daily face-to-face consultation via video link to ensure these patients, are appropriately managed in the community. In extreme cases where neither video nor teleconferencing is appropriate for managing patients, these patients can be followed up with home visits ensuring that the appropriate personal protective equipment is worn by the healthcare workers involved. An outreach worker ASHA (Accredited Social Health Activist), one of the key members of National Rural Health Mission, India will have to make a home visit to a TB patient to check if patient is adhering to the treatment [17] . 3.2 Diabetes is estimated to be the cause of 15% of active TB cases, due to impaired host defences caused by diabetes. TB Patients with concurrent diabetes have severe cavitating disease, adverse treatment outcomes, a higher rate of recurrence following Anti-tubercular treatment, and a higher risk of mortality from TB than patients with TB alone [18] . Remote management and monitoring of both diabetes mellitus and TB possible with telemedicine will address both diseases [13] . for COVID-19 testing without compromising their use for TB [20] . Recently Indian Council of Medical Research (ICMR) also has approved the use of 'TruenatTM beta CoV test on TruelabTM workstation' which were used for testing drug-resistant tuberculosis as a screening test for COVID-19 [21] . occur during the current COVID-19 pandemic is possible [25] . Damage caused by the TB infection can predispose a patient to COVID-19. Patients who concurrently develop COVID -19 tend to show a worse prognosis, probably due to pre-existing lung damage from the TB infection. Therefore patients should be tested for either disease if there is clinical deterioration, even if the clinical picture is atypical [26] . The testing of TB patients for COVID -19 is applicable to both patients at home as well as patients who are inpatients, including those who are deemed high risk i.e. HIV positive patients [27] . Nigeria Ministry of Health has identified TB as one of the risk factors for severe COVID-19 infection and death [28] . Nigeria has similar profile of endemic presence of TB like India. There are concerning reports suggesting that COVID-19 may slow down the recent gains in TB control [28] . Tandolini et al [30] report Anti-TB treatment does not provide immunity against They emphasize the importance of strict infection control measures for all hospital patients especially those with higher risk e.g. elderly patients with co-morbidities. COVID-19 pandemic: Non-COVID-19 health services like TB surveillance has been hampered with focus on the emergency planning for the pandemic including improving rates of COVID-19 testing and organising quarantine facilities [8] . There is a concern that there may be a surge in number of patients with TB once the lockdown is lifted. Effective Utilization of Nikshay Aushadhi; a web enabled application, which facilitates monitoring of universal access to all TB patients including Multi-Drug Resistant cases is required during COVID-19 pandemic [32] . There has been a worldwide concern about the availability of PPE and paucity of protective materials such as hand sanitizers, mask, and gowns. PPEs shortage in health centers make it impossible for health care workers to provide safe regular health-care services for patient with tuberculosis [33] . This affects sampling of patients with active TB and their transport to central government laboratory since health workers are reluctant taking samples due lack of appropriate PPE. with the latest WHO guidelines, must be ensured for all TB patients, including those in COVID-19 quarantine and those with confirmed COVID-19 disease [7] . People-centered outpatient and community-based care should be strongly preferred over hospital treatment for TB patients as this will not only prevent patient from a in-hospital visit, but also allow monitoring of uptake of anti-TB drugs. This will reduce chances of drug resistant TB [27] . TB patients likely to be at increased risk of COVID-19 infection so it is advisable that TB patients should continue treatment and take precautions like social distancing, mask, and hand hygiene to protect themselves from COVID-19. Recent study showed there are cases of multidrug-resistant TB cases not put on treatment after being diagnosed due to COVID-19 [34] . pandemic has been hampered by the difficulties health care workers face in carrying out COVID-19 duties during lockdown impacting on the non -COVID-19 health services like that of TB and Malaria. In these extraordinary times, the health care providers must adapt and be flexible. Health Care Workers (HCWs) continue to safeguard themselves, their colleagues, their families, and their patients in this crisis. They need to be protected and supported. However there are reports of rising violence against the health care workers undertaking testing and contact tracing of patients [35, 36] . pandemic [37] . There has been rising debate about the role of BCG in reducing the impact of COVID-19 [38] . 13 . Economic consequences of COVID-19 pandemic: Together the social, economic, and biomedical consequences of the COVID-19 pandemic have created a perfect storm with respect to tuberculosis disease management [39] . A recent study from United Nations advocate that the long-lasting social and economic impacts of the COVID-19 pandemic could threaten public health programmes and disproportionately affect poorer people in poorer countries like Africa, South-East Asia, and Central and South America which are also the areas with the high tuberculosis burden [40] . An increase in tuberculosis transmission and new cases is expected to be worsened by COVID-19-associated economic challenges. Impact on health due to undernutrition and constraints on funding of public welfare programmes is likely to increase susceptibility to tuberculosis and other communicable diseases [39] . • Conflict of interest statement None • Statement of Ethics: Not required. • Funding Statement: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. • Competing interests: None declared. • Disclosure Statement: Nothing to disclose A Novel Coronavirus from Patients with Pneumonia in China Clinical course, and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single centered, retrospective, observational study Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease World Health Organisation (WHO) India under COVID-19 lockdown Central Tuberculosis Division Government of India. Ministry of Health and Family Welfare. (MOHFW) eSanjeevani-an integrated telemedicine solution Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians Redefining diabetic foot disease management service during COVID-19 pandemic COVID-19 Strategy update 14 Ministry of Health and Family Welfare (MOHFW) National Tuberculosis Elimination Program Ministry of Health and Family Welfare (MOHFW) Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes Government of India. Ministry of Electronics and Information Technology GeneXpert® platform for rapid molecular testing for SARS-CoV-2 in the WHO European Region European Laboratory Initiative on TB, HIV and Viral Hepatitis ICMR approves use of diagnostic machine for drug resistant TB for COVID-19 Comorbidity, and its impact on 1590 patients with Covid-19 in China: a nationwide analysis Active or latent tuberculosis increases susceptibility to COVID19 and disease severity COVID-19 and tuberculosis: A mathematical model-based forecasting in Delhi, India COVID-19 in Tuberculosis patients: a report of three cases World Health Organisation (WHO) Information Note: COVID-19: Considerations for Tuberculosis (TB) Care Tuberculosis and HIV responses threatened by COVID-19 Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity Active tuberculosis, sequelae, and COVID19co-infection: first cohort of 49 cases Tuberculosis, COVID-19, and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis Community preparedness for COVID-19 and frontline health workers in Chhattisgarh COVID-19: Indian government vows to protect health care workers from violence amid rising cases The plight of Health Care Workers in India duding COVID-19 pandemic World Health Organisation (WHO) Regional office for Europe. Guidance on routine immunization services during COVID-19 pandemic in the WHO European Region Considering BCG vaccination to reduce the impact of COVID-19 COVID-19, tuberculosis and poverty: preventing a perfect storm Estimates of the impact of COVID-19 on global poverty COVID-19 pandemic has made significant impact on Tuberculosis surveillance and management 2. Diabetes increases risk of both Tuberculosis and COVID-19 infection Simultaneous testing for both TB and COVID-19 should be performed on atypical symptomatic patients COVID-19 pandemic should not affect the continuity of Tuberculosis National programs